MINING.COM

Eventer Technologies Announces C$2,475,000 Private Placement of Units

Thursday, July 2, 2026 4:20 PM PDT

(via TheNewswire)

Vancouver, BC – July 2, 2026 – TheNewswire – Eventer Technologies Ltd. (the “Company” or “Eventer”) (TSXV: EVNT), a SaaS-based platform for the management and sale of tickets for live events, is pleased to announce that it will be proceeding with a non-brokered private placement of up to 33,000,000 units (the "Offered Units") at a price of C$0.075 per Offered Unit for gross proceeds of up to C$2,475,000 (the "Offering").

Each Offered Unit will be comprised of one (1) common share in the capital of the Company (each, a “Unit Share”) and one (1) transferable common share purchase warrant (each, a “Unit Warrant”) entitling the holder thereof to acquire one common share in the capital of the Company (each, a “Unit Warrant Share”) at a price in USD equivalent to C$0.10 per Unit Warrant Share for a period of 36 months from the date of issuance thereof. The Unit Warrants will also have an acceleration provision whereby upon the securities of Eventer being approved for trading on the Nasdaq Stock Market, Eventer will accelerate the expiry date of 50% of the unexercised Unit Warrants.

The Company intends to use the net proceeds of the Offering for general working capital purposes, including the evaluation of prospective transactions, settlement of liabilities, and other corporate and administrative expenses.

The Unit Shares and Unit Warrants issued under the Offering will be subject to a statutory hold period expiring four months and one day from the date of issuance of such Offered Units.

The Company may pay finder's fees on a portion of the Offering, subject to applicable securities legislation. Closing of the Offering is subject to approval of the TSX Venture Exchange. It is not anticipated that any new insiders will be created, nor that any change of control will occur, ‎as a result of the Offering. Any participation by insiders of the Company in the Offering will be on the same terms as arm’s length investors.

None of the securities sold in connection with the Offering will be registered under the United States Securities Act of 1933, as amended, and no such securities may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Eventer

Eventer is an Israeli technology company operating a SaaS-based platform for the management and sale of tickets for live events, including performances, festivals, conferences, lectures, courses, nightlife events and other consumer experiences. The Company provides event organizers with an end-to-end operational platform designed to support the full lifecycle of an event, including ticket sales management, attendee administration, marketing tools, customer support services and event-entry solutions. In addition to its software platform, Eventer provides ancillary services to organizers, including sales and marketing support and secure payment processing solutions through third-party service providers.

For further information, please contact:

Yossi Lapovsky

CFO

Eventer Technologies Ltd.

Telephone: 972 50 9079929

Email: yossi@eventer.co.il

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include, but are not limited to, statements regarding: the completion of the Offering and the anticipated size and timing thereof; the receipt of all necessary approvals, including the acceptance of the TSX Venture Exchange; the anticipated use of the net proceeds of the Offering; the terms of the Offered Units, Unit Shares and Unit Warrants, including the exercise price and term of the Unit Warrants and the potential acceleration of their expiry; the potential listing or trading of the Company's securities on the Nasdaq Stock Market; the payment of finder's fees; and the expectation that no new insiders will be created and no change of control will occur as a result of the Offering.

Forward-looking statements are based on a number of assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied, including, without limitation: the Company's ability to complete the Offering on the announced terms and timing, or at all; the failure to obtain, or delays in obtaining, required regulatory and TSX Venture Exchange acceptance; the state of the capital markets and general economic conditions; the Company's ability to satisfy the conditions to, and the timing of, any Nasdaq listing; risks inherent in the Company's clinical-stage business; and the risk factors described in the Company's continuous disclosure filings available under its profile on SEDAR+ at www.sedarplus.ca.

Although the Company believes that the assumptions and expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on them, as the Company can give no assurance that they will prove to be correct. The forward-looking statements in this news release are made as of the date hereof, and the Company undertakes no obligation to update or revise them, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.